We are live on ! Find out more
TCP

Tyndall Capital Partners Portfolio holdings

AUM $452K
1-Year Est. Return 26.52%
This Fund
S&P 500
This Quarter Est. Return
+25.95%
1 Year Est. Return
+26.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.48M
AUM Growth
+$623K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 45.53%
2 Financials 45.07%
3 Miscellaneous 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRAW icon
1
Traws Pharma
TRAW
$9.24M
$1.58M 45.53%
93
MMAC
2
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$1.57M 45.07%
67,399
ONTXW
3
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$327K 9.4%
390,624

Similar funds

Tyndall Capital Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Tyndall Capital Partners held 3 positions worth $3.48M, up 22% from $2.85M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2017: portfolio turnover was 0%. Tyndall Capital Partners opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 41% a quarter earlier, followed by Financials and Miscellaneous.

  • Tyndall Capital Partners's ten largest holdings make up 100% of its $3.48M portfolio in Q1 2017.
  • Tyndall Capital Partners opened 0 new positions and closed 0 in Q1 2017.
  • Tyndall Capital Partners's portfolio value rose 22% quarter-over-quarter to $3.48M.

Based on Tyndall Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.